KHASIGO BR SYP (Terbutaline Sulphate 1.25 mg + Bromhexine Hydrochloride 4 mg + Guaiphenesin 50 mg + Menthol 2.5 mg)

Composition:
Each 5 ml contains Terbutaline Sulphate 1.25 mg, Bromhexine Hydrochloride 4 mg, Guaiphenesin 50 mg, and Menthol 2.5 mg along with a flavored syrup base and approved excipients.

Description:
Khasigo BR Syrup is a combination formulation used for the management of productive cough associated with bronchospasm. Terbutaline acts as a bronchodilator to relax airway muscles, Bromhexine helps in thinning and loosening mucus, Guaiphenesin acts as an expectorant to facilitate mucus clearance, and Menthol provides a soothing effect on the throat. The combination helps relieve cough, chest congestion, and breathing difficulty.

Precautions:
Use under medical supervision. Caution is advised in patients with cardiovascular disorders, hypertension, diabetes, or thyroid disorders. Not recommended in severe uncontrolled asthma without proper medical guidance. Do not exceed the prescribed dosage.

Adverse Effects:
Common side effects may include nausea, vomiting, headache, tremors, palpitations, or dizziness. Rarely, hypersensitivity reactions may occur.

Storage:
Store in a cool and dry place. Protect from direct sunlight. Keep the bottle tightly closed after use. Keep out of reach of children.